State Street Corp Intra Cellular Therapies, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, State Street Corp holds 1,874,875 shares of ITCI stock, worth $246 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,874,875

Previous 1,858,915 0.86%

Holding current value

$246 Million

Previous $136 Million 15.2%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$71.19 - $91.57 $1.14 Million - $1.46 Million	15,960 Added 0.86%	1,874,875 $157 Million
Q3 2024 Nov 14, 2024	BUY	$67.99 - $80.84 $3.85 Million - $4.58 Million	56,664 Added 3.14%	1,858,915 $136 Million
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $28.4 Million - $35 Million	-438,444 Reduced 19.57%	1,802,251 $123 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $1.28 Million - $1.5 Million	19,845 Added 0.89%	2,240,695 $155 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $3.96 Million - $6.29 Million	85,415 Added 4.0%	2,220,850 $159 Million
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $1.55 Million - $1.91 Million	29,730 Added 1.41%	2,135,435 $111 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $4.35 Million - $5.28 Million	79,477 Added 3.92%	2,105,705 $133 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1.37 Million - $1.78 Million	31,225 Added 1.57%	2,026,228 $110 Million
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $827,634 - $1.02 Million	18,780 Added 0.95%	1,995,003 $106 Million
Q3 2022 Nov 15, 2022	BUY	$42.7 - $59.99 $2.41 Million - $3.38 Million	56,408 Added 2.94%	1,976,223 $92 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $5.47 Million - $8.35 Million	127,285 Added 7.1%	1,919,815 $110 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $10.5 Million - $16.8 Million	269,892 Added 17.73%	1,792,530 $110 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $1.43 Million - $2.18 Million	-40,737 Reduced 2.61%	1,522,638 $79.7 Million
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $1.82 Million - $2.69 Million	63,346 Added 4.22%	1,563,375 $58.3 Million
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $479,641 - $728,465	16,370 Added 1.1%	1,500,029 $61.2 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $3.97 Million - $5.09 Million	-128,942 Reduced 8.0%	1,483,659 $50.3 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $4.5 Million - $6.21 Million	192,683 Added 13.57%	1,612,601 $51.3 Million
Q3 2020 Nov 10, 2020	BUY	$17.61 - $31.86 $975,277 - $1.76 Million	55,382 Added 4.06%	1,419,918 $36.4 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $1.86 Million - $3.46 Million	129,722 Added 10.51%	1,364,536 $35 Million
Q1 2020 May 11, 2020	BUY	$12.31 - $33.12 $15.2 Million - $40.9 Million	1,234,814 New	1,234,814 $19 Million

Others Institutions Holding ITCI

# of Institutions

418

Shares Held

88.6M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Intra Cellular Therapies, Inc. Transaction History